CLVLY
Price
$7.85
Change
+$0.08 (+1.03%)
Updated
Dec 3 closing price
Capitalization
401.25M
Intraday BUY SELL Signals
CSLLY
Price
$60.45
Change
-$0.09 (-0.15%)
Updated
Dec 3 closing price
Capitalization
58.13B
Intraday BUY SELL Signals
Interact to see
Advertisement

CLVLY vs CSLLY

Header iconCLVLY vs CSLLY Comparison
Open Charts CLVLY vs CSLLYBanner chart's image
Clinuvel Pharmaceuticals
Price$7.85
Change+$0.08 (+1.03%)
Volume$4.12K
Capitalization401.25M
CSL
Price$60.45
Change-$0.09 (-0.15%)
Volume$104.7K
Capitalization58.13B
CLVLY vs CSLLY Comparison Chart in %
CLVLY
Daily Signal:
Gain/Loss:
CSLLY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLVLY vs. CSLLY commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLVLY is a Hold and CSLLY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CLVLY: $7.65 vs. CSLLY: $59.81)
Brand notoriety: CLVLY and CSLLY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLVLY: 45% vs. CSLLY: 160%
Market capitalization -- CLVLY: $390.68M vs. CSLLY: $58.36B
CLVLY [@Biotechnology] is valued at $390.68M. CSLLY’s [@Biotechnology] market capitalization is $58.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLVLY’s FA Score shows that 1 FA rating(s) are green whileCSLLY’s FA Score has 1 green FA rating(s).

  • CLVLY’s FA Score: 1 green, 4 red.
  • CSLLY’s FA Score: 1 green, 4 red.
According to our system of comparison, CLVLY is a better buy in the long-term than CSLLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLVLY’s TA Score shows that 5 TA indicator(s) are bullish while CSLLY’s TA Score has 4 bullish TA indicator(s).

  • CLVLY’s TA Score: 5 bullish, 3 bearish.
  • CSLLY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CLVLY is a better buy in the short-term than CSLLY.

Price Growth

CLVLY (@Biotechnology) experienced а +8.97% price change this week, while CSLLY (@Biotechnology) price change was +1.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSLLY($58.1B) has a higher market cap than CLVLY($401M). CSLLY has higher P/E ratio than CLVLY: CSLLY (19.59) vs CLVLY (16.63). CLVLY YTD gains are higher at: -0.199 vs. CSLLY (-30.313). CSLLY has higher annual earnings (EBITDA): 5.13B vs. CLVLY (57.2M). CSLLY has higher revenues than CLVLY: CSLLY (15.4B) vs CLVLY (95M).
CLVLYCSLLYCLVLY / CSLLY
Capitalization401M58.1B1%
EBITDA57.2M5.13B1%
Gain YTD-0.199-30.3131%
P/E Ratio16.6319.5985%
Revenue95M15.4B1%
Total CashN/A1.52B-
Total DebtN/A12B-
FUNDAMENTALS RATINGS
CLVLY vs CSLLY: Fundamental Ratings
CLVLY
CSLLY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
2
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5096
PRICE GROWTH RATING
1..100
6062
P/E GROWTH RATING
1..100
6588
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSLLY's Valuation (2) in the null industry is in the same range as CLVLY (3). This means that CSLLY’s stock grew similarly to CLVLY’s over the last 12 months.

CSLLY's Profit vs Risk Rating (100) in the null industry is in the same range as CLVLY (100). This means that CSLLY’s stock grew similarly to CLVLY’s over the last 12 months.

CLVLY's SMR Rating (50) in the null industry is somewhat better than the same rating for CSLLY (96). This means that CLVLY’s stock grew somewhat faster than CSLLY’s over the last 12 months.

CLVLY's Price Growth Rating (60) in the null industry is in the same range as CSLLY (62). This means that CLVLY’s stock grew similarly to CSLLY’s over the last 12 months.

CLVLY's P/E Growth Rating (65) in the null industry is in the same range as CSLLY (88). This means that CLVLY’s stock grew similarly to CSLLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLVLYCSLLY
RSI
ODDS (%)
Bullish Trend 6 days ago
58%
Bullish Trend 6 days ago
65%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 6 days ago
51%
Momentum
ODDS (%)
Bullish Trend 6 days ago
58%
Bullish Trend 6 days ago
53%
MACD
ODDS (%)
Bullish Trend 6 days ago
70%
Bullish Trend 6 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
63%
Bullish Trend 6 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
80%
Bullish Trend 6 days ago
49%
Advances
ODDS (%)
Bullish Trend 22 days ago
61%
Bullish Trend 6 days ago
51%
Declines
ODDS (%)
Bearish Trend 15 days ago
77%
Bearish Trend 14 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
62%
Bearish Trend 6 days ago
53%
Aroon
ODDS (%)
Bearish Trend 6 days ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLVLY
Daily Signal:
Gain/Loss:
CSLLY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMKIX15.02N/A
N/A
American Century Emerging Markets I
ARIIX10.86N/A
N/A
AB Global Real Estate Investment II I
TISCX30.20N/A
N/A
Nuveen Large Cap Responsible Eq R6
DRDIX25.49N/A
N/A
Dearborn Partners Rising Dividend I
BIDEX11.36N/A
N/A
BlackRock Defensive Advantage EM Instl

CLVLY and

Correlation & Price change

A.I.dvisor tells us that CLVLY and ATNM have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLVLY and ATNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLVLY
1D Price
Change %
CLVLY100%
N/A
ATNM - CLVLY
20%
Poorly correlated
N/A
BSEM - CLVLY
11%
Poorly correlated
N/A
CMXHF - CLVLY
10%
Poorly correlated
N/A
BVNRY - CLVLY
8%
Poorly correlated
N/A
CSLLY - CLVLY
4%
Poorly correlated
N/A
More

CSLLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSLLY has been loosely correlated with ADPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CSLLY jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSLLY
1D Price
Change %
CSLLY100%
N/A
ADPT - CSLLY
34%
Loosely correlated
-0.80%
RXRX - CSLLY
34%
Loosely correlated
-0.69%
VIR - CSLLY
33%
Poorly correlated
-7.17%
FOLD - CSLLY
33%
Poorly correlated
-0.71%
CDXS - CSLLY
33%
Poorly correlated
-0.30%
More